Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS)

CNY 40.96

(2.24%)

Revenue Summary of Shanghai Yizhong Pharmaceutical Co., Ltd.

  • Shanghai Yizhong Pharmaceutical Co., Ltd.'s latest annual revenue in 2023 was 360.25 Million CNY , up 52.0% from previous year.
  • Shanghai Yizhong Pharmaceutical Co., Ltd.'s latest quarterly revenue in 2024 Q2 was 52.96 Million CNY , down -22.54% from previous quarter.
  • Shanghai Yizhong Pharmaceutical Co., Ltd. reported a annual revenue of 235.95 Million CNY in annual revenue 2022, up 5686.75% from previous year.
  • Shanghai Yizhong Pharmaceutical Co., Ltd. reported a annual revenue of 4.07 Million CNY in annual revenue 2021, down 0.0% from previous year.
  • Shanghai Yizhong Pharmaceutical Co., Ltd. reported a quarterly revenue of 47.45 Million CNY for 2024 Q3, down -10.41% from previous quarter.
  • Shanghai Yizhong Pharmaceutical Co., Ltd. reported a quarterly revenue of 68.37 Million CNY for 2024 Q1, down -15.25% from previous quarter.

Annual Revenue Chart of Shanghai Yizhong Pharmaceutical Co., Ltd. (2023 - 2017)

Historical Annual Revenue of Shanghai Yizhong Pharmaceutical Co., Ltd. (2023 - 2017)

Year Revenue Revenue Growth
2023 360.25 Million CNY 52.0%
2022 235.95 Million CNY 5686.75%
2021 4.07 Million CNY 0.0%
2020 - CNY 0.0%
2019 - CNY 0.0%
2018 - CNY 0.0%
2017 - CNY 0.0%

Peer Revenue Comparison of Shanghai Yizhong Pharmaceutical Co., Ltd.

Name Revenue Revenue Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 9.65 Billion CNY 96.269%
Yabao Pharmaceutical Group Co., Ltd 2.9 Billion CNY 87.619%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 75.51 Billion CNY 99.523%
Harbin Pharmaceutical Group Co., Ltd. 15.33 Billion CNY 97.651%
Tasly Pharmaceutical Group Co., Ltd 8.54 Billion CNY 95.784%
Zhejiang Medicine Co., Ltd. 7.79 Billion CNY 95.378%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 8.22 Billion CNY 95.619%
Lionco Pharmaceutical Group Co.,Ltd. 196.83 Million CNY -83.027%
Humanwell Healthcare (Group) Co.,Ltd. 24.33 Billion CNY 98.519%
Ginwa Enterprise (Group) Inc. 565.4 Million CNY 36.284%
Joincare Pharmaceutical Group Industry Co.,Ltd. 16.64 Billion CNY 97.836%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 644.97 Million CNY 44.144%
China Animal Husbandry Industry Co., Ltd. 5.4 Billion CNY 93.336%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 860.93 Million CNY 58.155%
Zhejiang Huahai Pharmaceutical Co., Ltd. 8.21 Billion CNY 95.613%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.87 Billion CNY 80.759%
Ningbo Menovo Pharmaceutical Co., Ltd. 1.21 Billion CNY 70.386%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 5.52 Billion CNY 93.478%
Chongqing Taiji Industry(Group) Co.,Ltd 15.43 Billion CNY 97.666%
HPGC Renmintongtai Pharmaceutical Corporation 10.38 Billion CNY 96.533%
Nanjing Well Pharmaceutical Group Co.,Ltd. 1.15 Billion CNY 68.832%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 3.73 Billion CNY 90.353%
Henan Lingrui Pharmaceutical Co., Ltd. 3.31 Billion CNY 89.121%
Shenzhen Chipscreen Biosciences Co., Ltd. 515.78 Million CNY 30.154%
Guizhou Yibai Pharmaceutical Co., Ltd. 2.77 Billion CNY 87.031%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 4.86 Billion CNY 92.599%
Zhongzhu Healthcare Holding Co.,Ltd 580.05 Million CNY 37.893%
Beijing Tongrentang Co., Ltd 17.86 Billion CNY 97.983%
KPC Pharmaceuticals, Inc. 7.62 Billion CNY 95.277%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 845.34 Million CNY 57.384%
North China Pharmaceutical Company Ltd. 10.12 Billion CNY 96.44%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 10.22 Billion CNY 96.476%
Tibet Weixinkang Medicine Co., Ltd. 1.32 Billion CNY 72.763%
China National Medicines Corporation Ltd. 49.69 Billion CNY 99.275%
Zhejiang Hisun Pharmaceutical Co., Ltd. 10.37 Billion CNY 96.527%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 3.13 Billion CNY 88.52%
ChengDu ShengNuo Biotec Co.,Ltd. 430.98 Million CNY 16.412%
Dali Pharmaceuticalco.,Ltd 87.26 Million CNY -312.804%
Changchun BCHT Biotechnology Co. 1.81 Billion CNY 80.115%
Zhejiang Shengda Bio-Pharm Co., Ltd. 727.4 Million CNY 50.474%
Shanghai Jiaoda Onlly Co.,Ltd 291.91 Million CNY -23.409%
Jiang Zhong Pharmaceutical Co.,Ltd 4.32 Billion CNY 91.675%
Mayinglong Pharmaceutical Group Co., LTD. 3.13 Billion CNY 88.515%
Cisen Pharmaceutical Co., Ltd. 4.46 Billion CNY 91.927%
Hunan Warrant Pharmaceutical Co.,Ltd 1.43 Billion CNY 74.856%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 41.39 Billion CNY 99.13%
Jianmin Pharmaceutical Group Co.,Ltd. 4.18 Billion CNY 91.39%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.62 Billion CNY 77.879%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 3.09 Billion CNY 88.366%
Guobang Pharma Ltd. 5.34 Billion CNY 93.266%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 672.96 Million CNY 46.467%
Kangmei Pharmaceutical Co., Ltd. 4.87 Billion CNY 92.609%
Shandong Buchang Pharmaceuticals Co., Ltd. 13.24 Billion CNY 97.28%
Zhejiang Starry Pharmaceutical Co.,Ltd. 2.17 Billion CNY 83.456%
Henan Taloph Pharmaceutical Stock Co.,Ltd 2.06 Billion CNY 82.596%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 3.79 Billion CNY 90.516%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 3.93 Billion CNY 90.836%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 932.12 Million CNY 61.351%
Shanghai Shyndec Pharmaceutical Co., Ltd. 11.93 Billion CNY 96.981%
Tibet Rhodiola Pharmaceutical Holding Co. 3.09 Billion CNY 88.364%
Sichuan Huiyu Pharmaceutical Co., Ltd. 920.34 Million CNY 60.857%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 671.62 Million CNY 46.361%
CanSino Biologics Inc. 345.18 Million CNY -4.366%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 2.17 Billion CNY 83.43%
Shandong Lukang Pharmaceutical Co.,Ltd. 6.14 Billion CNY 94.139%